Klaria Pharma Offers Up to 61,494,038 Warrants in Rights Issue

• Klaria Pharma Holding's unit rights issue closes November 6, 2026, targeting up to SEK 147.6 million before costs.
• The offering comprises up to 61,494,038 units at SEK 2.4 each, with four new shares and one free TO1 warrant per unit.
• Each TO1 warrant entitles holders to subscribe for one new share at SEK 0.6 during five exercise periods spanning November 2027–October 2029.
• Full exercise of all TO1 warrants issued under a fully subscribed offering could raise an additional SEK 36.9 million before costs.
• Unexercised warrants expire worthless following the final exercise period, October 17–31, 2029.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Klaria Pharma Holding AB published the original content used to generate this news brief via Cision (Ref. ID: 202611060820BITN____UKPR__SV_20261106-BIT-5934-0) on November 06, 2026, and is solely responsible for the information contained therein.